Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 245

1.

TNF-alpha inhibitors in dermatology.

Cordoro KM, Feldman SR.

Skin Therapy Lett. 2007 Sep;12(7):4-6. Review.

PMID:
17940711
[PubMed - indexed for MEDLINE]
Free Article
2.

TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis.

Tobin AM, Kirby B.

BioDrugs. 2005;19(1):47-57. Review.

PMID:
15691217
[PubMed - indexed for MEDLINE]
3.

Management of severe psoriasis with TNF antagonists. Adalimumab, etanercept and infliximab.

Mossner R, Reich K.

Curr Probl Dermatol. 2009;38:107-36. doi: 10.1159/000232307. Epub 2009 Jul 28. Review.

PMID:
19710553
[PubMed - indexed for MEDLINE]
4.

Anti-TNF agents for the treatment of psoriasis.

Kircik LH, Del Rosso JQ.

J Drugs Dermatol. 2009 Jun;8(6):546-59. Review.

PMID:
19537380
[PubMed - indexed for MEDLINE]
5.

Use of etanercept in the dermatology setting. A review.

Lebwohl MG.

Am J Clin Dermatol. 2005;6(1):49-59. Review. Erratum in: Am J Clin Dermatol. 2005;6(3):202.

PMID:
15675890
[PubMed - indexed for MEDLINE]
6.

Off-label dermatologic uses of anti-TNF-a therapies.

Alexis AF, Strober BE.

J Cutan Med Surg. 2005 Dec;9(6):296-302. Review.

PMID:
16699906
[PubMed - indexed for MEDLINE]
7.

TNF alpha inhibition as treatment modality for certain rheumatologic and gastrointestinal diseases.

Wiedmann MW, Mössner J, Baerwald C, Pierer M.

Endocr Metab Immune Disord Drug Targets. 2009 Sep;9(3):295-314. Epub 2009 Sep 1. Review.

PMID:
19594416
[PubMed - indexed for MEDLINE]
8.

Safety and efficacy of the tumor necrosis factor antagonists.

Bachmann F, Nast A, Sterry W, Philipp S.

Semin Cutan Med Surg. 2010 Mar;29(1):35-47. doi: 10.1016/j.sder.2010.02.002. Review.

PMID:
20430306
[PubMed - indexed for MEDLINE]
9.

Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.

Woolacott N, Bravo Vergel Y, Hawkins N, Kainth A, Khadjesari Z, Misso K, Light K, Asseburg C, Palmer S, Claxton K, Bruce I, Sculpher M, Riemsma R.

Health Technol Assess. 2006 Sep;10(31):iii-iv, xiii-xvi, 1-239. Review.

PMID:
16948890
[PubMed - indexed for MEDLINE]
Free Article
10.

Safety of anti-TNFα agents in the treatment of psoriasis and psoriatic arthritis.

Girolomoni G, Altomare G, Ayala F, Berardesca E, Calzavara-Pinton P, Chimenti S, Peserico A, Puglisi Guerra A, Vena GA.

Immunopharmacol Immunotoxicol. 2012 Aug;34(4):548-60. doi: 10.3109/08923973.2011.653646. Epub 2012 Feb 2. Review.

PMID:
22296031
[PubMed - indexed for MEDLINE]
11.

Differentiating the efficacy of tumor necrosis factor inhibitors.

Haraoui B.

J Rheumatol Suppl. 2005 Mar;74:3-7. Review.

PMID:
15742457
[PubMed - indexed for MEDLINE]
12.

Adalimumab (Humira) restores clinical response in patients with secondary loss of efficacy from infliximab (Remicade) or etanercept (Enbrel): results from the STURE registry at Karolinska University Hospital.

Wick MC, Ernestam S, Lindblad S, Bratt J, Klareskog L, van Vollenhoven RF.

Scand J Rheumatol. 2005 Sep-Oct;34(5):353-8.

PMID:
16234182
[PubMed - indexed for MEDLINE]
13.

Efficacy and safety of subcutaneous anti-tumor necrosis factor-alpha agents, etanercept and adalimumab, in elderly patients affected by psoriasis and psoriatic arthritis: an observational long-term study.

Esposito M, Giunta A, Mazzotta A, Zangrilli A, Babino G, Bavetta M, Perricone R, Chimenti S, Chimenti MS.

Dermatology. 2012;225(4):312-9. doi: 10.1159/000345623. Epub 2012 Dec 28.

PMID:
23295383
[PubMed - indexed for MEDLINE]
14.

[Etanercept].

Sparsa A.

Ann Dermatol Venereol. 2005 Nov;132(11 Pt 1):861-76. Review. French.

PMID:
16327716
[PubMed - indexed for MEDLINE]
15.

Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris.

Gniadecki R, Kragballe K, Dam TN, Skov L.

Br J Dermatol. 2011 May;164(5):1091-6. doi: 10.1111/j.1365-2133.2011.10213.x. Epub 2011 Apr 11.

PMID:
21219290
[PubMed - indexed for MEDLINE]
16.

Potential of tumor necrosis factor inhibitors in psoriasis and psoriatic arthritis.

Krueger G, Callis K.

Arch Dermatol. 2004 Feb;140(2):218-25. Review.

PMID:
14967799
[PubMed - indexed for MEDLINE]
17.

Interstitial granulomatous dermatitis associated with the use of tumor necrosis factor alpha inhibitors.

Deng A, Harvey V, Sina B, Strobel D, Badros A, Junkins-Hopkins JM, Samuels A, Oghilikhan M, Gaspari A.

Arch Dermatol. 2006 Feb;142(2):198-202.

PMID:
16490847
[PubMed - indexed for MEDLINE]
18.

TNF- alpha inhibitors.

Jackson JM.

Dermatol Ther. 2007 Jul-Aug;20(4):251-64. Review. Erratum in: Dermatol Ther. 2008 Mar-Apr;21(2):150.

PMID:
17970890
[PubMed - indexed for MEDLINE]
19.

Etanercept for psoriasis: two case reports.

Fidalgo A, Baptista J, Rocha Páris F, Caldas Lopes L, Ferreira A.

Int J Clin Pharmacol Res. 2005;25(4):159-63.

PMID:
16402631
[PubMed - indexed for MEDLINE]
20.

Newly available treatments for psoriatic arthritis and their impact on skin psoriasis.

Galadari H, Fuchs B, Lebwohl M.

Int J Dermatol. 2003 Mar;42(3):231-7. Review.

PMID:
12653923
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk